Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT00627627Withdrawn
-
NCT00322504Completed
-
NCT00940199Completed
-
NCT00291122Completed
-
NCT00428896Completed
-
NCT00378638Unknown
-
NCT00245869Completed
-
NCT07085442RecruitingBreast Cancer | Axillary Lymph Nodes Dissection | Axillary Metastases | Axilla; Breast | Node Positive Breast Cancer | Axillary Ultrasound | Sentinel Lymph Node Biopsy (SLNB)
-
NCT04597580Active, not recruitingBreast Cancer Metastatic | Estrogen Receptor-positive Breast Cancer
-
-
NCT04252859TerminatedInvasive Lobular Breast Carcinoma
-
NCT02648477CompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma
-
NCT02015897CompletedBreast Cancer | Lymphoedema
-
NCT03606616CompletedBreast Cancer | Sentinel Lymph Node | Local Recurrence of Malignant Tumor of Breast
-
NCT03560102TerminatedBreast Cancer, Invasive Ductal
-
NCT02803736UnknownBreast Cancer | Lymphedema | Acupuncture
-
NCT06126640RecruitingHER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
-
NCT05860907Not yet recruiting
-
NCT05188495RecruitingHER2-positive Metastatic Breast Cancer | Previously Treated With Trastuzumab | Trastuzumab Combined With Pertuzumab and Chemotherapy
-
NCT04337658Not yet recruiting
-
-
NCT01898117Active, not recruiting
-
NCT05424835Active, not recruitingHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
-
NCT05016310CompletedBreast Cancer | Osteoporosis | Breast
-
NCT04678544Completed
-
NCT05161507CompletedBreast Carcinoma | Breast Carcinoma Metastatic in Lymph Node
-
NCT05427617CompletedMetastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
-
NCT01064427UnknownNewly Diagnosed Breast Cancer | Surgery Programmed
-
NCT06762483Recruiting
-
NCT05989347RecruitingBreast Cancer | Hyperinsulinism | HER2-negative Breast Cancer
-
NCT05900895RecruitingMetastatic Breast Cancer
-
-
NCT06540612CompletedQuality of Life | Breast Cancer Female | Survivorship
-
NCT06690489CompletedQuality of Life | Skin Condition | Early Breast Cancer
-
NCT04493333TerminatedVaginal Atrophy | Breast Cancer Female | Postmenopausal Symptoms | Long-term Survivors
-
NCT04540471WithdrawnMusic Therapy, Breast Cancer, Anxiety, Fatigue
-
NCT06091696CompletedPost-operative Breast Cancer
-
NCT01554371CompletedMalignant Solid Tumour | Breast Cancer Nos Metastatic Recurrent | Neuropathy
-
NCT04729647CompletedBreast Cancer | Breast Cancer Invasive
-
NCT02802098CompletedMetastatic Breast Cancer | Bevacizumab-alone Maintenance Treatment Progression
-
NCT03348696CompletedPain Syndrome | Early-stage Breast Cancer
-
NCT01511276Completed
-
NCT02992769Unknown
-
NCT01018251WithdrawnAdult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)
-
NCT01557478UnknownStage II and III Breast Cancer
-
NCT07318805RecruitingColorectal Cancer | Advanced Breast Cancer | Triple Negative Breast Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Breast Cancer (HR+/ HER2-)
-
NCT05982496Not yet recruitingBreast Cancer Female | Lobular Breast Carcinoma | PET/MRI | Axillary Lymphadenopathy | Luminal a Breast Cancer
-
NCT05111561SuspendedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast Carcinoma
-
NCT03500380Active, not recruitingBreast Neoplasms | Breast Diseases | HER2-positive Breast Cancer | Capecitabine | HER2 Positive Breast Carcinoma | HER2-positive Advanced Breast With Liver Metastases
-
NCT02556632CompletedPain | Breast Carcinoma | Stage 0 Breast Cancer | Radiation-Induced Dermatitis